| Literature DB >> 32624707 |
Wanqing Weng1,2, Zhongjing Zhang1, Weiguo Huang1, Xiangxiang Xu1, Boda Wu1,2, Tingbo Ye1, Yunfeng Shan3, Keqing Shi1,2, Zhuo Lin4.
Abstract
[This corrects the article DOI: 10.1186/s12935-020-01243-6.].Entities:
Year: 2020 PMID: 32624707 PMCID: PMC7329454 DOI: 10.1186/s12935-020-01381-x
Source DB: PubMed Journal: Cancer Cell Int ISSN: 1475-2867 Impact factor: 5.722
Fig. 6Multi-mRNAs-based classifier. a, b PAAD patients in the training cohort and the validation cohort were classified into predicted low and high-risk groups according to the multi-mRNAs-based classifier. b, d Kaplan–Meier survival analysis of the multi-mRNAs-based classifier was performed. e, g Time-dependent ROC curve and calibration curves of the multi-mRNAs-based classifier in the training cohort. f Time-dependent ROC curve of the multi-mRNAs-based classifier in the validation cohort